Navigation Links
deCODE genetics Announces Third Quarter 2008 Financial Results
Date:11/6/2008

be webcast tomorrow, Friday, November 7, at 8:00am US Eastern Standard Time/1pm GMT. The webcast can be accessed via the Investors section of deCODE's website, http://www.decode.com, or through http://www.earnings.com. A replay of the call will be available on these websites for at least one week following the call. A digitized telephone replay of the call can be accessed for the week following the call by dialing 1-800-475-6701 from the US, or +1-320-365-3844 from outside the US. The access code is 967723.

Condensed Consolidated Statements of Operations

For the three months For the nine months

ended September 30, ended September 30,

2008 2007 2008 2007

in thousands, except per share amounts (unaudited)

Revenue $ 11,978 $ 10,892 $ 41,982 $ 27,060

Operating expenses

Cost of revenue 10,992 11,976 39,138 32,050

Research and development 5,652 14,069 26,269 41,273

Selling, general and

administrative 6,661 7,070 21,018 19,395

Total operating expense 23,305 33,115 86,425 92,718

Operating loss (11,327) (22,223) (44,443) (65,658)

Interest income 500 1,646 1,989 5,155

Interest expense (4,187) (4,019) (12,332) (11,488)

Other non-operating

income and

(expense), net* (2,886) 348 (8,133) 8,890

Net loss $ (17,900) $ (24,248) $ (62,919) $ (63,101)

Basic and diluted

net loss per share: $ (0.29) $ (0.40) $ (1.03) $ (1.03)

Shares used in

computing ba
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...wswire-USNewswire/ -- The Appignani Bioethics Cent..., held a panel discussion today at the National Pr...ogies in biomedical sciences and climate change. T...w Light, both of the Center for American Progress,...cal angles. ,, A video of the event will be ma...
(Date:11/9/2009)...Newswire-Asia/ -- The pharma and biotech sectors a...panies are facing significant,pressure to change w..., calls for,lower prices and a greater regulatory ...al crisis have made the work of creating new drugs...e being forced to globalize their R&D,operatio...
(Date:11/9/2009)...PRNewswire/ -- Following the provision of clinical...istration (FDA), privately,owned UK company Daval ...nal.com ) has been informed that its innovative,an...an Orphan-Drug,designation for the treatment of Am... also known as Lou Gehrig,s disease, is the most c...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- BioSpecifics Technologies...ny developing first-in-class collagenase-based pro...he third quarter ended September 30, 2009. ,, ...s year, the FDA,s Arthritis Advisory Committee una...val of XIAFLEX(TM) for the treatment of Dupuytren,...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...n of the Board -, MADISON, N.J., April 24 Wyeth ...obert Essner, 60, has decided to retire,from the C...d the position,of Chairman since January 2003 and ...1 to 2007. The Company,s Board of Directors has el... Executive Officer, to the,additional position of ...
...Inc.,(Nasdaq: HOLX ), a diversified medical techn...imaging products and interventional devices dedica...y announced plans to release its,second quarter fi...08 at,8:00 a.m. (eastern). In conjunction with the...n Thursday, May 1, 2008 at 9:00 a.m. (eastern)., ...
...ewswire-FirstCall/ -- China Sky One,Medical, Inc. ...lletin,Board: CSKI), a pharmaceutical company for ...s Republic of China ("PRC"), today announced it,ac...ina Pharmaceutical"), a,recently formed corporatio... 2008., China Sky One Medical, Inc., through its ...
Other Biology Technology:Wyeth Chairman Robert Essner Announces June 27 Retirement 2Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 3
(Date:11/9/2009)...e of butterfly wings has inspired a 3.2m, three-ye...ation in the fields of security, energy and the en...nal technology company QinetiQ have just signed a ... based on groundbreaking physical sciences researc...ists from the University of Exeter and QinetiQ wil...
(Date:11/9/2009)...rlands, November 09, 2009 / b3c newswire / - To...and Seventh Wave, an American organization for con...companies have signed a letter of intent with rega...els TIM. The letter of intent proposes a collabora...tems for commercialization in North America. The T...
(Date:11/9/2009)...cientists and industry leaders from around the wor... AACR-NCI-EORTC Molecular Targets and Cancer Thera...re groundbreaking information on important cancer ...x disease and to treat it effectively we need a gr...ce at the molecular level," said Lewis Cantley, Ph...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Take A Swing Against Breast Cancer 21 51913 1Take A Swing Against Breast Cancer 21 51913 2ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 1ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 2Mettler Toledo International Inc to Host Second Quarter 2009 Earnings Conference Call 51904 1
...NY, October 30, 2008 Bayhill Therapeutics, Inc., ...seases, and the Juvenile Diabetes Research Foundat... 1 diabetes research, today announced a partnershi...inical trial of BHT-3021, a DNA vaccine to reverse..., BHT-3021 is an antigen-specific immunotherapeut...
...raits that we look for typically include a sense o...isma. However, a recent study suggests that it is ...cation skills that determine who is chosen as lead...at there is a gender bias when selecting leaders; ...end on the specific situation that a group finds i...
...rs at Georgetown University Medical Center have di...become resistant to tamoxifen, the world,s largest...ug. They say the findings could provide a way to i...ng from the drug, allowing doctors to try another ...f the journal Cancer Research, the researchers s...
Other Biology News:Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 2Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 3Gender biases in leadership selection during competitions within and between groups 2Gender biases in leadership selection during competitions within and between groups 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
Mouse Anti-Human LAT, phospho (Tyr226) Monoclonal Antibody, Unconjugated, Clone J96-1238.58.93 from BD Biosciences Pharmingen
TE Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade from Research Organics, Inc.
...t-effective solution to your TechMate Detection re...lity into both our products and service capabiliti... antibodies that have been optimized to the TechMa...iced accessories that can be purchased individuall...
PAP PEN from Invitrogen
Biology Products: